about
Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysisUsing a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot studyCytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression.Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention.Commentary on the ECTRIMS-EAN guideline for pharmacological treatment of multiple sclerosis.Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Personalised medicine for multiple sclerosis care.
@en
type
label
Personalised medicine for multiple sclerosis care.
@en
prefLabel
Personalised medicine for multiple sclerosis care.
@en
P2093
P2860
P356
P1476
Personalised medicine for multiple sclerosis care.
@en
P2093
Arie Gafson
Matt J Craner
Paul M Matthews
P2860
P304
P356
10.1177/1352458516672017
P577
2016-09-26T00:00:00Z